V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002725 | 240008645 | 1.76 | 71.7 | 03 | 2017-11-07 | 2017-11-13 | CNS Low Grade Glioma Vinblastine | N | N | NHL INTB NHL RITUX2010 GPB COPADM | 101098146 |
| 240002729 | 240008647 | 1.65 | 45.9 | Curative (C) | 2020-03-17 | 2020-05-01 | IBRUTINIB | 02 | N | DABRAFENIB | 101464129 |
| 240002730 | 240008648 | null | 102.4 | 03 | 2020-08-26 | 2020-09-02 | Venetoclax | 02 | null | AML MYECHILD 01 A MITOZANTRONE/CYTARABINE | 100332081 |
| 240002731 | 240008649 | 1.62 | 22.5 | Neo-adjuvant (N) | 2018-06-11 | 2018-07-16 | AML MyeChild | 02 | N | FLAG + IDARUBICIN | 100882868 |
| 240002733 | 240008650 | 1.72 | 79.5 | Palliative (P) | 2019-10-14 | 2019-10-16 | AML MyeChild 01 FLA-Idarubicin | 02 | N | IBRUTINIB | 101528355 |
| 240002739 | 240008652 | 1.75 | 94 | Curative (C) | 2019-07-25 | 2019-07-30 | ALL UKALL2011 IndB Std Dex (PegAsp) | 02 | N | PACLITAXEL | 100407138 |
| 240002752 | 240008654 | 1.7 | 58.6 | null | 2019-03-08 | 2019-06-07 | Ibrutinib + Rituximab | 01 | null | AML MYECHILD 01 ARM E MAC HSCT | 101242258 |
| 240002754 | 240008655 | 1.55 | 95.5 | Curative (C) | 2017-06-19 | 2017-06-19 | ALL UKALL2011 IndB Std Dex (PegAsp) | 02 | null | CNS LGG2004 03 VINC + CARBO | 100630392 |
| 240002758 | 240008658 | 1.82 | 71.4 | Curative (C) | null | 2019-11-25 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | null | N | CHLORAMBUCIL | 100059680 |
| 240002761 | 240008660 | 1.63 | 52.5 | null | 2017-07-14 | 2017-08-25 | DABRAFENIB | 01 | null | RUXOLITINIB | 101043271 |
| 240002767 | 240008662 | 1.7 | 86.4 | Curative (C) | null | 2019-04-01 | FLAG + Idarubicin | N | null | BUSULFAN | 100160514 |
| 240002768 | 240008663 | 0 | 69 | 03 | 2018-01-26 | 2018-02-17 | ALL UKALL2011 Std BFM Cons B | 02 | null | AML16 TRIAL | 100081712 |
| 240002773 | 240008667 | 1.73 | 123.4 | Curative (C) | 2019-11-17 | 2019-11-22 | IVE | 02 | N | RUXOLITINIB | 101607667 |
| 240002775 | 240008668 | 1.84 | 73.4 | null | 2017-01-18 | 2017-01-19 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | CVP R | 101733692 |
| 240002777 | 240008670 | null | null | null | 2017-08-21 | 2017-08-29 | null | 02 | null | AML MYECHILD 01 A MITOZANTRONE/CYTARABINE | 101584198 |
| 240002779 | 240008671 | 0 | 76.2 | Curative (C) | 2018-08-17 | 2018-09-21 | AML MyeChild 01 HD AraC | 02 | null | CYCLOPHOSPHAMIDE | 101576750 |
| 240002781 | 240008673 | 1.63 | 73.6 | Palliative (P) | 2017-11-07 | 2017-11-08 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CYTARABINE HIGH DOSE | 101178629 |
| 240002787 | 240008675 | 0 | 88 | Palliative (P) | 2019-09-06 | 2019-10-05 | null | null | N | ALL INT GDE 2019 MAINTENANCE | 100469034 |
| 240002788 | 240008676 | 0 | 77 | Curative (C) | 2020-03-14 | 2020-03-21 | FLUDARABINE + MELPHALAN | N | null | FLAIR TRIAL | 101542502 |
| 240002789 | 240008677 | 0 | 14.4 | Curative (C) | 2021-02-27 | 2021-03-06 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | CYTARABINE + DAUNORUBICIN + GEMTUZUMAB OZOGAMICIN | 100666387 |
| 240002791 | 240008679 | 1.63 | 92.8 | null | 2017-02-01 | 2017-02-01 | LIPOSOMAL DAUNORUBICIN + CYTARABINE (Vyxeos) | 02 | null | BUSULFAN | 101162074 |
| 240002796 | 240008680 | 1.9 | 52 | null | 2018-05-13 | 2018-05-21 | IBRUTINIB | 2 | null | CRIZOTINIB | 100390967 |
| 240002798 | 240008681 | 1.76 | 0 | Curative (C) | 2016-10-06 | 2016-10-06 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | ALCL ALCL 99 CLOSED AM 1, 2 OR 3 | 100442675 |
| 240002799 | 240008682 | 1.61 | 59.3 | Curative (C) | 2020-08-18 | 2020-08-24 | R-EPOCH | 02 | N | ANAGRELIDE | 100748689 |
| 240002803 | 240008684 | 1.71 | 67.3 | null | null | 2017-09-09 | CAR-T Yescarta + Fludarabine + Cyclophosphamide | Y | null | RUXOLITINIB | 101292001 |
| 240002805 | 240008685 | 1.58 | 105.5 | Palliative (P) | 2020-09-03 | 2020-09-04 | DABRAFENIB | 01 | null | IDELALISIB | 100141254 |
| 240002811 | 240008687 | 1.62 | 60 | Palliative (P) | 2018-12-17 | 2018-12-18 | IBRUTINIB | 02 | N | AML MYECHILD 01 TRIPLE IT | 101321394 |
| 240002817 | 240008690 | 1.6 | 97.2 | Curative (C) | 2019-04-16 | 2019-08-20 | ALL Interim Guide 2019 Maintenance | 02 | N | CARBOPLATIN + VINCRISTINE | 100255854 |
| 240002824 | 240008692 | 0 | 105 | Curative (C) | 2019-10-16 | 2019-10-27 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | null | N | ANTI-THYMOCYTE GLOBULIN + BUSULFAN + FLUDARABINE | 101276743 |
| 240002825 | 240008693 | 1.76 | 75.35 | Palliative (P) | 2016-08-02 | 2016-08-12 | CLADRIBINE | null | N | FLAIR TRIAL | 100345964 |
| 240002826 | 240008694 | 1.62 | 75 | null | 2018-08-25 | 2018-08-25 | AML Int Guide ADE 10+3+5 (1) | null | null | CHLORAMBUCIL + OBINUTUZUMAB | 101539970 |
| 240002831 | 240008697 | null | null | null | 2020-10-04 | 2020-11-14 | null | 02 | null | ICE-R | 100005624 |
| 240002836 | 240008699 | 1.62 | 76 | Palliative (P) | 2021-01-27 | 2021-02-05 | Cytarabine High Dose | 02 | N | CISPLATIN + GEMCITABINE | 101188698 |
| 240002839 | 240008700 | 1.73 | 73.4 | Curative (C) | null | 2018-10-19 | null | N | null | IBRUTINIB + RITUXIMAB | 100264509 |
| 240002841 | 240008701 | 1.65 | 63.8 | 03 | 2018-08-10 | 2018-11-03 | FLAIR trial | 01 | null | CARBOPLATIN + VINCRISTINE | 100670116 |
| 240002845 | 240008704 | 1.82 | 93 | Curative (C) | 2016-05-06 | 2016-08-02 | Imatinib 400mg | 01 | N | ANAGRELIDE | 101713235 |
| 240002849 | 240008707 | 1.75 | 52 | null | 2017-10-06 | 2017-10-18 | AML MyeChild | N | null | CNS LOW GRADE GLIOMA VINBLASTINE | 101758104 |
| 240000237 | 240008710 | 1.64 | 86 | 03 | null | 2021-08-26 | Venetoclax | 01 | N | TRABECTEDIN | 100510652 |
| 240000288 | 240008711 | 0 | 57.9 | Curative (C) | 2020-02-09 | 2020-02-10 | null | 01 | N | IMATINIB | 100026639 |
| 240000434 | 240008714 | 1.67 | 61 | Disease modification (D) | 2019-01-30 | 2019-02-06 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | N | ETOPOSIDE | 100244785 |
| 240000506 | 240008715 | null | 55 | Disease modification (D) | 2019-06-12 | 2019-06-19 | Dasatinib | null | null | RUXOLITINIB | 100084458 |
| 240000533 | 240008716 | 1.75 | 53.9 | null | 2019-12-04 | 2019-12-17 | RUXOLITINIB | 02 | null | CNS LGG 2004 03 VINC WEEKLY+ CARBO | 100823555 |
| 240000600 | 240008717 | 1.8 | 28.25 | null | 2018-10-23 | 2018-10-23 | DA-EPOCH-R | N | null | NHL 2003 GP B COP | 101379375 |
| 240000626 | 240008719 | 0 | 37 | Curative (C) | 2017-07-26 | 2017-10-19 | Cyclophosphamide High Dose | 02 | N | AML MYECHILD 01 FLA-IDARUBICIN | 101019381 |
| 240000718 | 240008721 | 1.67 | null | 03 | 2018-08-07 | 2018-08-07 | Venetoclax | 02 | null | AML MYECHILD 01 TRIPLE IT | 100996040 |
| 240000970 | 240008723 | 1.62 | 28.45 | null | 2022-05-29 | 2022-05-29 | FLAG + Idarubicin | 02 | null | TRIPLE INTRATHECAL | 100916897 |
| 240001015 | 240008724 | 1.72 | 85.7 | null | 2016-06-16 | 2016-06-21 | Venetoclax | 02 | null | AZACITIDINE + VENETOCLAX | 101156464 |
| 240001123 | 240008725 | 1.86 | 70.6 | Curative (C) | 2019-07-01 | 2019-07-08 | Venetoclax | N | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101055953 |
| 240001189 | 240008726 | 1.82 | null | null | 2022-02-18 | 2022-02-19 | RUXOLITINIB | 02 | null | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 101530642 |
| 240001704 | 240008731 | 1.68 | 97.5 | null | 2018-04-14 | 2018-04-14 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | CISPLATIN + GEMCITABINE + RITUXIMAB | 100060121 |